Business and Finance

New unit will ship from La Vergne, TN specialty-care products warehouse

Specialty GPO is doubling attendance year-over-year

US total reaches $291.5 billion; dispensed prescriptions up 0.9%

Although human trials in the U.S. are still a novelty, developers are identifying both sources and protocols for conducting therapy

Although beset by less-than-friendly federal reimbursement policies, independent pharmacies are maintaining their viability for pharmaceutical delivery

Higher complexity—and expense—are the reality for most drug research, says Tufts

Higher co-pays, ‘NDC block policies’ and multiple tiers add to drug benefit complexity

New Deloitte study finds “profound” positive and negative ROIs for combined therapies and diagnostics based on genetics